It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
This study describes the synthesis of novel 1-(α,α-diphenyl-α-hydroxy)acetyl-4- substitutedthiosemicarbazide (2a-k), [5-(substitutedamino)-1,3,4-thiadiazole-2-yl](diphenyl) methanol (3a-b) and 3-[hydroxy(diphenyl)methyl]-4-(nonsusbtituted/substituted)-2,4-dihydro- 5H-1,2,4-triazole-5-thione derivatives (4a-c) and evaluation of their cytotoxic activities. In the course of the syntheses benzilic acid methyl ester was reacted with hydrazine hydrate in absolute ethanol to afford benzilic acid hydrazide (1). Reaction of 1 with appropriate alkyl/ arylisothiocyanates gave 1-(α,α-diphenyl-α-hydroxy)acetyl-4-substitutedthiosemicarbazide (2a-k). [5-(substitutedamino)-1,3,4-thiadiazole-2-yl](diphenyl)methanol derivatives (3a-b) were obtained by cyclization of 2a and 2c with concentrated sulphuric acid. On the other hand, 3-[hydroxy(diphenyl)methyl]-4-(nonsusbtituted/substituted)-2,4-dihydro-5H-1,2,4-triazole- 5-thione (4a-c) were obtained by cyclization of 2c, 2d and 2g with 2N NaOH. The structures of the new compounds were confirmed by the data obtained from elemental analysis, HPLC, UV, IR, 1H-NMR, 13C-NMR, HSQC and MS spectra. Compounds 2a, 2c-k, 3b and 4b were selected for cytotoxic screening by using HEK293 cell line of MTT assay. The highest inhibition were confirmed as 50.23% at 10 mg/ml for the compound 1-(α,α-diphenyl-α- hydroxy)acetyl-4-cyclohexylmethylthiosemicarbazide (2e).
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer